These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33314384)

  • 41. Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index.
    Deckers K; Köhler S; Ngandu T; Antikainen R; Laatikainen T; Soininen H; Strandberg T; Verhey F; Kivipelto M; Solomon A
    Alzheimers Dement; 2021 Jul; 17(7):1205-1212. PubMed ID: 33403822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gender-Specific Design and Effectiveness of Non-Pharmacological Interventions against Cognitive Decline - Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zülke AE; Riedel-Heller SG; Wittmann F; Pabst A; Röhr S; Luppa M
    J Prev Alzheimers Dis; 2023; 10(1):69-82. PubMed ID: 36641611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Eligibility Criteria on Patient Selection and Treatment Implications from 10 Multidomain Dementia Prevention Trials: A Population-Based Study.
    Licher S; Wolters FJ; Pavlović J; Kavousi M; Leening MJG; Ikram MK; Ikram MA
    Neuroepidemiology; 2023; 57(1):14-24. PubMed ID: 36398446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial.
    Sindi S; Solomon A; Kåreholt I; Hovatta I; Antikainen R; Hänninen T; Levälahti E; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Peltonen M; Singh Khalsa D; Wolozin B; Strandberg T; Tuomilehto J; Soininen H; Ngandu T; Kivipelto M;
    J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):491-498. PubMed ID: 33175128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study.
    Jia L; Du Y; Chu L; Zhang Z; Li F; Lyu D; Li Y; Li Y; Zhu M; Jiao H; Song Y; Shi Y; Zhang H; Gong M; Wei C; Tang Y; Fang B; Guo D; Wang F; Zhou A; Chu C; Zuo X; Yu Y; Yuan Q; Wang W; Li F; Shi S; Yang H; Zhou C; Liao Z; Lv Y; Li Y; Kan M; Zhao H; Wang S; Yang S; Li H; Liu Z; Wang Q; Qin W; Jia J;
    Lancet Public Health; 2020 Dec; 5(12):e661-e671. PubMed ID: 33271079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uptake and effectiveness of a tailor-made online lifestyle programme targeting modifiable risk factors for dementia among middle-aged descendants of people with recently diagnosed dementia: study protocol of a cluster randomised controlled trial (Demin study).
    Vrijsen J; Abu-Hanna A; Maeckelberghe EL; De Deyn PP; de Winter AF; Reesink FE; Oude Voshaar RC; Buskens E; de Rooij SE; Smidt N;
    BMJ Open; 2020 Oct; 10(10):e039439. PubMed ID: 33067294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multidomain interventions based on a life-course model to prevent dementia in at-risk Chinese older adults: A randomized controlled trial.
    Meng X; Su J; Gao T; Ma D; Zhao Y; Fang S; Zhi S; Li H; Sun J
    Int J Nurs Stud; 2024 Apr; 152():104701. PubMed ID: 38330865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lifestyle for Brain Health (LIBRA): a new model for dementia prevention.
    Schiepers OJG; Köhler S; Deckers K; Irving K; O'Donnell CA; van den Akker M; Verhey FRJ; Vos SJB; de Vugt ME; van Boxtel MPJ
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):167-175. PubMed ID: 28247500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentially modifiable dementia risk factors in all Australians and within population groups: an analysis using cross-sectional survey data.
    See RS; Thompson F; Russell S; Quigley R; Esterman A; Harriss LR; Hyde Z; Taylor S; Radford K; LoGiudice D; McDermott R; Livingston G; Strivens E
    Lancet Public Health; 2023 Sep; 8(9):e717-e725. PubMed ID: 37633680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
    Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review.
    Coley N; Giulioli C; Aisen PS; Vellas B; Andrieu S
    Ageing Res Rev; 2022 Dec; 82():101777. PubMed ID: 36336171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proportion of dementia in Australia explained by common modifiable risk factors.
    Ashby-Mitchell K; Burns R; Shaw J; Anstey KJ
    Alzheimers Res Ther; 2017 Feb; 9(1):11. PubMed ID: 28212674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modifiable Risk Factors for Dementia: The Role of Gut Microbiota.
    Cabrera C; Vicens P; Torrente M
    Curr Alzheimer Res; 2021; 18(13):993-1009. PubMed ID: 34911422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Online assessment of risk factors for dementia and cognitive function in healthy adults.
    Huntley J; Corbett A; Wesnes K; Brooker H; Stenton R; Hampshire A; Ballard C
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e286-e293. PubMed ID: 28960500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design.
    Ponvel P; Shahar S; Singh DKA; Ludin AFM; Rajikan R; Rajab NF; Ai-Vyrn C; Din NC; Ibrahim N; Subramaniam P; Haron H; Ismail A; Sharif R; Ramasamy K; Majeed ABA; Ali NM; Mohamad M; Noah SAM; Ibrahim AM; Safien AM; Khalid NM; Fadzil NHM; Mangialasche F; Kivipelto M
    J Alzheimers Dis; 2021; 82(2):673-687. PubMed ID: 34092633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A qualitative study to inform adaptations to a brain health intervention for older adults with type 2 diabetes living in rural regions of Ireland.
    McEvoy CT; Regan-Moriarty J; Dolan C; Bradshaw C; Mortland V; McCallion M; McCarthy G; Kennelly SP; Kelly J; Heffernan M; Kee F; McGuinness B; Passmore P
    Diabet Med; 2023 Apr; 40(4):e15034. PubMed ID: 36572988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life.
    Gates NJ; Rutjes AW; Di Nisio M; Karim S; Chong LY; March E; Martínez G; Vernooij RW
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012277. PubMed ID: 30864187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample.
    Pons A; LaMonica HM; Mowszowski L; Köhler S; Deckers K; Naismith SL
    J Alzheimers Dis; 2018; 62(1):373-384. PubMed ID: 29439337
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.